Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancer

Yehui Shi(Tianjin Medical University Cancer Institute and Hospital), Hui Li(Tianjin Medical University Cancer Institute and Hospital)

Cancer Immunology Immunotherapy

July 6, 2020

10.1007/s00262-020-02653-1

Cited by 71

Related Papers

SH3BGRL confers innate drug resistance in breast cancer by stabilizing HER2 activation on cell membrane

|Journal of Experimental & Clinical Cancer Research|2020|40

HDAC6-Dependent Deacetylation of TAK1 Enhances sIL-6R Release to Promote Macrophage M2 Polarization in Colon Cancer

|Research Square|2022|0